Related Experiment Videos
Lithium-induced nephrogenic diabetes insipidus.
1Rapid City Regional Hospital Family Practice Residency Program, SD 57701, USA.
The Journal of the American Board of Family Practice
|March 2, 1999
Summary
Lithium can cause persistent nephrogenic diabetes insipidus (NDI) years after discontinuation. Patients with a history of lithium use require monitoring for NDI symptoms and hypernatremia risk.
Area of Science:
- Nephrology
- Pharmacology
- Endocrinology
Background:
- Lithium treatment is associated with nephrogenic diabetes insipidus (NDI) in 20-40% of patients.
- A subset of patients experience persistent NDI, a concentrating defect, even after lithium cessation.
- This condition poses a risk for severe hypernatremia, particularly during fluid restriction.
Observation:
- A case report details a patient with persistent NDI 8 years post-lithium discontinuation.
- This represents the longest reported duration of persistent lithium-induced NDI.
- The patient developed hypernatremia when polydipsia was managed by staff.
Findings:
- Persistent NDI after lithium cessation is a documented phenomenon.
- The precise mechanism underlying persistent lithium-related NDI remains unknown.
- Acute lithium-induced NDI is linked to alterations in intracellular cyclic adenosine monophosphate.
Implications:
- Patients on current lithium therapy and those with a past history require vigilant monitoring for NDI.
- Healthcare providers must recognize the potential for delayed-onset or persistent NDI in lithium-treated patients.
- Appropriate patient care and monitoring are crucial to prevent complications like hypernatremia.